Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Dynamic MRI clarifies the effect of chemotherapy on tumor vascularity
December 22nd, 2005
Dynamic contrast MRI (DCE-MRI) clarifies the effect of chemotherapy on tumor vascularity. "DCE-MRI is being used increasingly in clinical trials to demonstrate that vascular disruptive and antiangiogenic agents target tumor microcirculation. Significant reductions in DCE-MRI kinetic parameters are seen within 4-24 and 48 h of treatment with vascular disruptive and antiangiogenic agents, respectively," researchers in England report. "It is important to know whether cytotoxic agents also cause significant acute reductions in these parameters, for reliable interpretation of results. This study investigated changes in transfer constant (K trans) and the...
Source: Women's Health Weekly (2005-12-22)
|
